septerna inc. - SEPN

SEPN

Close Chg Chg %
22.50 -0.71 -3.16%

Closed Market

21.79

-0.71 (3.16%)

Volume: 153.75K

Last Updated:

Nov 21, 2024, 4:00 PM EDT

Company Overview: septerna inc. - SEPN

SEPN Key Data

Open

$22.76

Day Range

21.67 - 23.30

52 Week Range

N/A - N/A

Market Cap

$945.06M

Shares Outstanding

42.00M

Public Float

28.66M

Beta

N/A

Rev. Per Employee

N/A

P/E Ratio

1,666.67

EPS

-$8.40

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

N/A

 

SEPN Performance

1 Week
 
-3.28%
 
1 Month
 
N/A
 
3 Months
 
N/A
 
1 Year
 
N/A
 
5 Years
 
N/A
 

SEPN Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 4
Full Ratings ➔

About septerna inc. - SEPN

Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native Complex PlatformTM. Its pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. The company was founded by Robert Joseph Lefkowitz, Arthur Christopoulos, Patrick Sexton, and Jeffrey T. Finer in December 2019 and is headquartered in South San Francisco, CA.

SEPN At a Glance

Septerna, Inc.
250 East Grand Avenue
South San Francisco, California 94080
Phone 1-650-338-3533 Revenue 151.00K
Industry Pharmaceuticals: Major Net Income 567.00K
Sector Health Technology Employees N/A
Fiscal Year-end 12 / 2024
View SEC Filings

SEPN Valuation

P/E Current 1,666.67
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio N/A
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA N/A
Enterprise Value to Sales N/A
Total Debt to Enterprise Value N/A

SEPN Efficiency

Revenue/Employee N/A
Income Per Employee N/A
Receivables Turnover 0.007
Total Asset Turnover 0.002

SEPN Liquidity

Current Ratio 16.297
Quick Ratio 16.297
Cash Ratio 12.798

SEPN Profitability

Gross Margin -461.589
Operating Margin -30,165.563
Pretax Margin 3,225.828
Net Margin 375.497
Return on Assets 0.679
Return on Equity 0.802
Return on Total Capital 0.459
Return on Invested Capital 0.737

SEPN Capital Structure

Total Debt to Total Equity 11.337
Total Debt to Total Capital 10.183
Total Debt to Total Assets 9.602
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 10.183
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Septerna Inc. - SEPN

Collapse All in section
All values USD millions. 2022 2023 5-year trend
Sales/Revenue
- - - 151.00K
-
Sales Growth
- - - -
-
Cost of Goods Sold (COGS) incl D&A
- - 577.00K 848.00K
-
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
- - 577.00K 848.00K
-
Depreciation
- - - -
-
Amortization of Intangibles
- - - -
-
COGS Growth
- - - +46.97%
-
Gross Income
- - (577.00K) (697.00K)
-
Gross Income Growth
- - - -20.80%
-
Gross Profit Margin
- - - -461.59%
-
2022 2023 5-year trend
SG&A Expense
- - 27.39M 44.85M
-
Research & Development
- - 22.04M 35.98M
-
Other SG&A
- - 5.35M 8.87M
-
SGA Growth
- - - +63.76%
-
Other Operating Expense
- - - -
-
Unusual Expense
- - - -
-
EBIT after Unusual Expense
- - (27.97M) (45.55M)
-
Non Operating Income/Expense
- - 291.00K 50.42M
-
Non-Operating Interest Income
- - 291.00K 2.79M
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
- - (27.68M) 4.87M
-
Pretax Income Growth
- - - +117.60%
-
Pretax Margin
- - - +3,225.83%
-
Income Tax
- - - 691.00K
-
Income Tax - Current - Domestic
- - - 200.00K
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - 491.00K
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - (3.61M)
-
Consolidated Net Income
- - (27.68M) 567.00K
-
Minority Interest Expense
- - - -
-
Net Income
- - (27.68M) 567.00K
-
Net Income Growth
- - - +102.05%
-
Net Margin Growth
- - - +375.50%
-
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
- - (27.68M) 567.00K
-
Preferred Dividends
- - - -
-
Net Income Available to Common
- - (27.68M) 567.00K
-
EPS (Basic)
- - -0.6589 0.0135
-
EPS (Basic) Growth
- - - +102.05%
-
Basic Shares Outstanding
- - 42.00M 42.00M
-
EPS (Diluted)
- - -0.6589 0.0135
-
EPS (Diluted) Growth
- - - +102.05%
-
Diluted Shares Outstanding
- - 42.00M 42.00M
-
EBITDA
- - (27.39M) (44.70M)
-
EBITDA Growth
- - - -63.21%
-
EBITDA Margin
- - - -29,603.97%
-

Snapshot

Average Recommendation BUY Average Target Price 43.667
Number of Ratings 4 Current Quarters Estimate -0.693
FY Report Date 12 / 2024 Current Year's Estimate -7.735
Last Quarter’s Earnings -8.40 Median PE on CY Estimate N/A
Year Ago Earnings N/A Next Fiscal Year Estimate -2.558
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 3 4 4
Mean Estimate -0.69 -0.54 -7.74 -2.56
High Estimates -0.42 -0.44 -5.19 -2.17
Low Estimate -0.83 -0.65 -10.38 -3.15
Coefficient of Variance -34.14 -19.75 -34.69 -16.79

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 4
OVERWEIGHT 0
HOLD 0
UNDERWEIGHT 0
SELL 0
MEAN Buy

Septerna Inc. in the News